Picture of Biotalys NV logo

BTLS — Biotalys NV News Story

0.000.00%
be flag iconLast trade - 00:00
Consumer DefensivesHighly SpeculativeSmall CapSucker Stock

Brief: Biotalys Says Achieves Breakthrough In Protein Expression For Evoca

Jan 25 (Reuters) - Biotalys NV  BTLS.BR :
    * BIOTALYS ACHIEVES BREAKTHROUGH IN PROTEIN EXPRESSION
INCREASING
COMMERCIAL POTENTIAL FOR ITS FIRST BIOFUNGICIDE EVOCA
    * NEXT GENERATION OF EVOCA PRODUCTS PROVIDES COMMERCIAL
POTENTIAL
AT 2026 HORIZON
    * REGISTRATION APPROVAL FIRST IN UNITED STATES BY
ENVIRONMENTAL
PROTECTION AGENCY (EPA) WHICH IS EXPECTED IN SECOND HALF OF 2022

Source text for Eikon:  ID:nGNEKDZzc 
Further company coverage:  BTLS.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Biotalys NV

See all news